Success Stories: EB-1A Approved for a Postdoctoral Fellow in Washington in the Field of Pharmacology
Client’s Testimonial:
I appreciate the assistance from the attorneys of your firm! I didn’t expect my I-140 petition to go so well. I have promoted your firm on MITBBS. I will strongly recommend your service among my colleagues as well!
On January 26th, 2015, We Received Another EB1-A (Alien of Extraordinary Ability) Approval for a Postdoctoral Fellow in the Field of Pharmacology (Approval Notice)
Position at the Time of Case Filing: Postdoctoral Fellow
Country of Origin: China
Service Center: Nebraska Service Center (NSC)
State of Residence at the Time of Filing: Washington
Approval Notice Date: January 26th, 2015
Processing Time: 4 months, 9 days
Our client in this case was a pharmacologist from China who had made numerous findings in the area of pharmacokinetics and drug transporters. His work had resulted in 13 peer-reviewed scientific articles and numerous presentations at national and international conferences; at the time that his case was filed, his publications had been cited at least 203 times by independent and leading researchers from prestigious institutions and organizations around the world, indicating the major significance of his work. He had also reviewed 23 manuscripts for 13 distinctive, internationally-circulated journals. An independent recommender remarked upon his superior expertise: “[Client] has achieved a position of prominence in biopharmaceutics and is recognized as an expert in OATs and DDIs. In light of the sizeable contributions made by [Client] to our understanding of OAT interactions with natural products, and considering the tremendous importance of documenting possible drug interactions with these compounds, it is clear that [Client] will remain a leader in the field and that his future contributions will be relied upon by countless other researchers.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that he sought to remain in the United States to continue work in the area of Pharmacology, and that his continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, his case was approved in 4 months and 9 days.